Lewis H. Titterton - Sep 29, 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Stock symbol
ANIX
Transactions as of
Sep 29, 2022
Transactions value $
$103,000
Form type
4
Date filed
9/30/2022, 10:34 AM
Previous filing
Sep 16, 2022
Next filing
Jan 4, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $103K +40K +5.45% $2.58 774K Sep 29, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option Options Exercise $0 -40K -100% $0.00* 0 Sep 29, 2022 Common Stock 40K $2.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, pursuant to a stock option grant dated February 15, 2013.